Johns Hopkins University: The Neurofibromatosis Therapeutic Acceleration Program
Tuesday, November 18, 2014
10:00 AM - 10:25 AM
GH - Empire Ballroom V
The Neurofibromatosis Therapeutic Acceleration Program (NTAP) is a philanthropically funded research program focused on developing effective treatments for neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (pNF). NF1 is a genetic neurological syndrome characterized by distinctive skin abnormalities and tumors causing disfigurement, pain, paralysis, and cancer. NTAP uses a highly collaborative approach working with international academic, government, and industry partners to develop research that fill critical gaps. An example of such a program is the cell culture initiative involving five academic scientists, the National Center for Advancing Translational Sciences, and Sage Bionetworks. Similar initiatives are creating patient-reported outcome measures and defining pNF natural history.
Jaishri Blakeley, Johns Hopkins University; The Neurofibromatosis Therapeutic Acceleration Program
View the presentation slides as a PDF